Title
|
FOA/Notice Number
|
Related |
Issuing Org
|
Released ▼
|
Opens
|
Expires
|
Activity Code
|
Advancing Conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS) by State, Local, Tribal, and Territorial (SLTT) Retail Food Regulatory Agencies (U2F) Clinical Trials Not Allowed |
RFA-FD-21-028 |
Related |
FDA
| 01-21-2021 |
01-19-2021 |
03-23-2021 |
U2F |
Nutrition for Precision Health, powered by the All of Us Research Program: Research Coordinating Center (U24 Clinical Trial Not Allowed) |
RFA-RM-21-006 |
Related |
RMOD
| 01-21-2021 |
03-05-2021 |
04-07-2021 |
U24 |
Nutrition for Precision Health, powered by the All of Us Research Program: Clinical Centers (UG1 Clinical Trial Required) |
RFA-RM-21-005 |
Related |
RMOD
| 01-21-2021 |
03-05-2021 |
04-07-2021 |
UG1 |
Nutrition for Precision Health, powered by the All of Us Research Program: Artificial Intelligence for Multimodal Data Modeling and Bioinformatics Center (U54 Clinical Trial Not Allowed) |
RFA-RM-21-001 |
Related |
RMOD
| 01-21-2021 |
03-05-2021 |
04-07-2021 |
U54 |
Nutrition for Precision Health, powered by the All of Us Research Program: Dietary Assessment Center (U24 Clinical Trial Optional) |
RFA-RM-21-004 |
Related |
RMOD
| 01-21-2021 |
03-05-2021 |
04-07-2021 |
U24 |
Nutrition for Precision Health, powered by the All of Us Research Program: Microbiome and Metagenomics Center (U24 Clinical Trial Not Allowed) |
RFA-RM-21-003 |
Related |
RMOD
| 01-21-2021 |
03-05-2021 |
04-07-2021 |
U24 |
Nutrition for Precision Health, powered by the All of Us Research Program: Metabolomics and Clinical Assays Center (U24 Clinical Trial Not Allowed) |
RFA-RM-21-002 |
Related |
RMOD
| 01-21-2021 |
03-05-2021 |
04-07-2021 |
U24 |
Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Optional) |
RFA-TR-21-008 |
Related |
NCATS
| 01-15-2021 |
03-19-2021 |
04-20-2021 |
UG3/UH3 |
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) |
RFA-EY-21-001 |
Related |
NEI
| 01-15-2021 |
04-02-2021 |
10-28-2023 |
R21 |
Infectious Etiology of Alzheimer's Disease (R01 Clinical Trial Optional) |
RFA-AG-21-034 |
Related |
NIA
| 01-15-2021 |
02-28-2021 |
04-01-2021 |
R01 |
Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required) |
RFA-TR-21-010 |
Related |
NCATS
| 01-13-2021 |
03-13-2021 |
01-13-2022 |
U44 |
Biomarkers for Diabetic Foot Ulcers through the Diabetic Foot Consortium (R61/R33 Clinical Trial Not Allowed) |
RFA-DK-21-001 |
Related |
NIDDK
| 01-13-2021 |
03-22-2021 |
11-04-2021 |
R61/R33 |
Renewal - Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations (U01) Clinical Trial Required |
RFA-FD-21-021 |
Related |
FDA
| 01-13-2021 |
01-18-2021 |
03-19-2021 |
U01 |
INTUIT-PC: Improving Nonsurgical Treatment of Urinary Incontinence among women in Primary Care: Dissemination and Implementation of PCOR Evidence (U18) |
RFA-HS-21-001 |
Related |
AHRQ
| 01-13-2021 |
01-13-2021 |
03-25-2021 |
U18 |
Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed) |
RFA-AI-20-078 |
Related |
NIAID
| 01-12-2021 |
05-04-2021 |
06-05-2021 |
U19 |
Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed) |
RFA-AI-20-077 |
Related |
NIAID
| 01-12-2021 |
05-04-2021 |
06-05-2021 |
U01 |
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required) |
RFA-DA-21-030 |
Related |
NIDA
| 01-11-2021 |
02-26-2021 |
03-27-2021 |
RM1 |
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Coordination and Dissemination Center (R24 Clinical Trial Optional) |
RFA-DA-21-029 |
Related |
NIDA
| 01-11-2021 |
02-26-2021 |
03-27-2021 |
R24 |
HEAL Initiative: Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional) |
RFA-MH-21-145 |
Related |
NIMH
| 01-11-2021 |
02-18-2021 |
03-19-2021 |
R01 |
HEAL Initiative: HEALthy Brain and Child Development Consortium Administrative Core (U24 - Clinical Trial Not Allowed) |
RFA-DA-21-022 |
Related |
NIDA
| 01-11-2021 |
03-01-2021 |
04-01-2021 |
U24 |
HEAL Initiative: HEALthy Brain and Child Development Data Coordinating Center (U24) |
RFA-DA-21-023 |
Related |
NIDA
| 01-11-2021 |
03-01-2021 |
04-01-2021 |
U24 |
HEAL Initiative: HEALthy Brain and Child Development Study (U01 - Clinical Trial Not Allowed) |
RFA-DA-21-021 |
Related |
NIDA
| 01-11-2021 |
03-01-2021 |
04-01-2021 |
U01 |
HEAL Initiative: HEALthy Brain and Child Development Study (Collaborative U01- Clinical Trial Not Allowed) |
RFA-DA-21-020 |
Related |
NIDA
| 01-11-2021 |
03-01-2021 |
04-01-2021 |
U01 |
HEAL Initiative: Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial - Clinical Sites (UG1 Clinical Trial Required) |
RFA-HD-21-031 |
Related |
NICHD
| 01-11-2021 |
02-28-2021 |
03-31-2021 |
UG1 |
HEAL Initiative: Data Coordinating Center for the Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial (U24 Clinical Trial Required) |
RFA-HD-21-032 |
Related |
NICHD
| 01-11-2021 |
02-28-2021 |
03-31-2021 |
U24 |
Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed) |
RFA-AG-21-033 |
Related |
NIA
| 01-08-2021 |
02-18-2021 |
03-19-2021 |
R01 |
Tuberculosis Research Advancement Centers (P30 Clinical Trials Not Allowed) |
RFA-AI-21-001 |
Related |
NIAID
| 01-07-2021 |
05-15-2021 |
06-16-2021 |
P30 |
Development of a model selection method for population pharmacokinetics analysis by deep-learning based reinforcement learning (U01) Clinical Trials Not Allowed |
RFA-FD-21-027 |
Related |
FDA
| 01-07-2021 |
01-18-2021 |
03-19-2021 |
U01 |
Quantify the expression of metabolizing enzymes and transporter proteins in lung, eye and skin tissue in relevant animal models and humans (U01) Clinical Trial Not Allowed |
RFA-FD-21-018 |
Related |
FDA
| 01-07-2021 |
01-15-2021 |
03-16-2021 |
U01 |
Development of Advanced Analytical Methods for the Characterization of Iron Carbohydrate Complex - Ferric Derisomaltose (U01) Clinical Trials Not Allowed |
RFA-FD-21-016 |
Related |
FDA
| 01-07-2021 |
01-18-2021 |
04-01-2021 |
U01 |
National Food and Nutrient Analysis Program (U01) Clinical Trial Not Applicable |
RFA-FD-21-023 |
Related |
FDA
| 01-07-2021 |
01-08-2021 |
03-10-2021 |
U01 |
Limited Competition: Revision to the Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required) |
RFA-DK-20-508 |
Related |
NIDDK
| 01-07-2021 |
03-14-2021 |
04-15-2021 |
U01 |
Computational Fluid Dynamics (CFD) Models to Aid the Development of Generic Inhalation Products (U01) Clinical Trials Optional |
RFA-FD-21-015 |
Related |
FDA
| 01-06-2021 |
01-12-2021 |
03-16-2021 |
U01 |
Physiologically Based Pharmacokinetic (PBPK) Models of Oral Absorption to Simulate the Results of Bioequivalence Studies (U01) Clinical Trials Optional |
RFA-FD-21-012 |
Related |
FDA
| 01-06-2021 |
01-15-2021 |
03-16-2021 |
U01 |
Next Generation Sequencing in Post Mortem Tissue from Patients with Parkinsons Disease (U01 Clinical Trial Not Allowed) |
RFA-NS-21-017 |
Related |
NINDS
| 01-06-2021 |
02-15-2021 |
03-16-2021 |
U01 |
Pilot and Feasibility Studies to Facilitate the Use of Diabetes Self-Management Education and Support to Improve Diabetes Care (R34 Clinical Trial Required) |
RFA-DK-20-032 |
Related |
NIDDK
| 01-06-2021 |
05-22-2021 |
06-23-2023 |
R34 |
Understanding and Reducing Cardiovascular Disease in Type 1 Diabetes Mellitus (R01 Clinical Trial Optional) |
RFA-HL-21-014 |
Related |
NHLBI
| 01-06-2021 |
02-15-2021 |
10-16-2021 |
R01 |
Cellular Senescence Network: Consortium Organization and Data Coordinating Center (U24 Clinical Trial Not Allowed) |
RFA-RM-21-010 |
Related |
RMOD
| 01-06-2021 |
02-08-2021 |
03-09-2021 |
U24 |
Cellular Senescence Network: Technology Development and Application (UG3/UH3 Clinical Trial Not Allowed) |
RFA-RM-21-009 |
Related |
RMOD
| 01-06-2021 |
02-08-2021 |
03-09-2021 |
UG3/UH3 |
Cellular Senescence Network: Tissue Mapping Centers (U54 Clinical Trial Not Allowed) |
RFA-RM-21-008 |
Related |
RMOD
| 01-06-2021 |
02-08-2021 |
03-09-2021 |
U54 |
New Approaches to Identify Neurogenesis and Study its Dynamics in Brain Aging and AD/ADRD (R01 Clinical Trial Not Allowed) |
RFA-AG-22-006 |
Related |
NIA
| 01-04-2021 |
05-17-2021 |
06-18-2021 |
R01 |
Improving Health Disparities in Alcohol Health Services (R01 Clinical Trial Optional) |
RFA-AA-21-001 |
Related |
NIAAA
| 12-28-2020 |
02-15-2021 |
03-16-2021 |
R01 |
Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R01 - Clinical Trials Not Allowed) |
RFA-DA-21-040 |
Related |
NIDA
| 12-28-2020 |
01-09-2021 |
02-10-2021 |
R01 |
Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R21 - Clinical Trials Not Allowed) |
RFA-DA-21-041 |
Related |
NIDA
| 12-28-2020 |
01-09-2021 |
02-10-2021 |
R21 |
Novel Approaches to Decrease Stigma of Substance Use Disorders in order to Facilitate Prevention, Treatment, and Support During Recovery (R43/R44 - Clinical Trials Optional) |
RFA-DA-21-016 |
Related |
NIDA
| 12-23-2020 |
01-26-2021 |
02-27-2021 |
R43/R44 |
Novel Approaches to Decrease Stigma of Substance Use Disorders in order to Facilitate Prevention, Treatment, and Support During Recovery (R41/R42 - Clinical Trials Optional) |
RFA-DA-21-015 |
Related |
NIDA
| 12-23-2020 |
01-26-2021 |
02-27-2021 |
R41/R42 |
Digital Technologies to Address the Social Determinants of Health in Context of Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) |
RFA-DA-21-032 |
Related |
NIDA
| 12-22-2020 |
12-26-2020 |
01-27-2021 |
R43/R44 |
Digital Technologies to Address the Social Determinants of Health in Context of Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) |
RFA-DA-21-031 |
Related |
NIDA
| 12-22-2020 |
12-26-2020 |
02-27-2021 |
R41/R42 |
Engaging the dental workforce to end the HIV epidemic in the U.S. (UG3/UH3 Clinical Trial Required) |
RFA-DE-21-002 |
Related |
NIDCR
| 12-14-2020 |
01-10-2021 |
02-11-2021 |
UG3/UH3 |
Renewal - Strengthen and Promote the Role of Local Health Departments in Retail Food Safety Regulation (U50 Clinical Trial Not Allowed |
RFA-FD-21-011 |
Related |
FDA
| 12-14-2020 |
12-14-2020 |
02-13-2021 |
U50 |
Limited Competition: National Institute on Aging (NIA) Late Onset of Alzheimers Disease (LOAD) Family-Based Study (FBS) (U24 Clinical Trial Not Allowed) |
RFA-AG-22-001 |
Related |
NIA
| 12-14-2020 |
01-17-2021 |
02-18-2021 |
U24 |
Renewal - Research, Education, and Outreach on Botanical Natural Products (U01) Clinical Trial Not Allowed |
RFA-FD-21-010 |
Related |
FDA
| 12-10-2020 |
12-14-2020 |
02-13-2021 |
U01 |
New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program (UG3/UH3 Clinical Trials Not Allowed) |
RFA-TR-21-001 |
Related |
NCATS
| 12-10-2020 |
06-08-2021 |
07-09-2021 |
UG3/UH3 |
Virtual Approaches Towards New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program (U18 Clinical Trials Not Allowed) |
RFA-TR-21-002 |
Related |
NCATS
| 12-10-2020 |
06-08-2021 |
07-09-2021 |
U18 |
Aging Effects on Osteoimmunology (R01 Clinical Trials Not Allowed) |
RFA-AG-22-002 |
Related |
NIA
| 12-10-2020 |
05-15-2021 |
06-16-2021 |
R01 |
Application of Artificial Intelligence and Machine Learning for Advancing Environmental Health Sciences (R41 Clinical Trial Not Allowed) |
RFA-ES-21-003 |
Related |
NIEHS
| 12-10-2020 |
02-28-2021 |
03-30-2021 |
R41 |
Application of Artificial Intelligence and Machine Learning for Advancing Environmental Health Sciences (R43 Clinical Trial Not Allowed) |
RFA-ES-21-002 |
Related |
NIEHS
| 12-10-2020 |
02-28-2021 |
03-30-2021 |
R43 |
Development of Methods to Evaluate the Impact of Design Differences to the User Interface of Generic Drug-Device Combination Products in Comparison to their Reference Listed Drugs (U01) Clinical Trials Optional |
RFA-FD-21-014 |
Related |
FDA
| 12-09-2020 |
12-15-2020 |
02-16-2021 |
U01 |
Physiologically-based pharmacokinetic (PBPK) models to aid the development of generic dermatological products (U01) Clinical Trials Optional |
RFA-FD-21-013 |
Related |
FDA
| 12-09-2020 |
12-15-2020 |
02-16-2021 |
U01 |
NIAMS Centers of Research Translation (CORT) (P50 - Clinical Trial Not Allowed) |
RFA-AR-22-001 |
Related |
NIAMS
| 12-09-2020 |
04-11-2021 |
05-12-2021 |
P50 |
Mood Disorders in People Living with HIV: Mechanisms and Pathways (R21 Clinical Trial Optional) |
RFA-MH-21-117 |
Related |
NIMH
| 12-09-2020 |
02-10-2021 |
03-11-2021 |
R21 |
Mood Disorders in People Living with HIV: Mechanisms and Pathways (R01 Clinical Trial Optional) |
RFA-MH-21-116 |
Related |
NIMH
| 12-09-2020 |
02-10-2021 |
03-11-2021 |
R01 |
Cellular Cancer Biology Imaging Research (CCBIR) Program (U54, Clinical Trial Not Allowed) |
RFA-CA-21-002 |
Related |
NCI
| 12-09-2020 |
02-18-2021 |
03-19-2021 |
U54 |
NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional) |
RFA-RM-20-022 |
Related |
RMOD
| 12-08-2020 |
01-28-2021 |
03-02-2021 |
U54 |
NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Coordination and Evaluation Center (U24 Clinical Trial Not Allowed) |
RFA-RM-20-023 |
Related |
RMOD
| 12-08-2020 |
01-29-2021 |
03-02-2021 |
U24 |
Renewal - Cooperative Agreement to Support Shellfish Assistance Project (U01) Clinical Trial Not Allowed |
RFA-FD-21-006 |
Related |
FDA
| 12-03-2020 |
12-03-2020 |
02-02-2021 |
U01 |
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional) |
RFA-CA-21-019 |
Related |
NCI
| 12-02-2020 |
05-09-2021 |
11-19-2021 |
U24 |
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional) |
RFA-CA-21-018 |
Related |
NCI
| 12-02-2020 |
05-08-2021 |
11-18-2021 |
U01 |
Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional) |
RFA-CA-21-017 |
Related |
NCI
| 12-02-2020 |
05-08-2021 |
11-18-2021 |
R01 |
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
RFA-CA-21-016 |
Related |
NCI
| 12-02-2020 |
05-08-2021 |
11-18-2021 |
U24 |
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
RFA-CA-21-015 |
Related |
NCI
| 12-02-2020 |
05-08-2021 |
11-18-2021 |
U24 |
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) |
RFA-CA-21-014 |
Related |
NCI
| 12-02-2020 |
05-08-2021 |
11-18-2021 |
U01 |
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) |
RFA-CA-21-013 |
Related |
NCI
| 12-02-2020 |
05-08-2021 |
11-18-2021 |
R21 |
Renewal - Federal and University Partnership to Improve the Safety of Seafood from the Gulf of Mexico (U19 Clinical Trials Not Allowed) |
RFA-FD-21-009 |
Related |
FDA
| 12-01-2020 |
12-03-2020 |
02-02-2021 |
U19 |
Summer Institute for Research Education in Biostatistics and Data Science (R25 Clinical Trial Not Allowed) |
RFA-HL-22-009 |
Related |
NHLBI
| 11-30-2020 |
02-08-2021 |
03-09-2021 |
R25 |
Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed) |
RFA-CA-21-001 |
Related |
NCI
| 11-25-2020 |
02-10-2021 |
03-11-2021 |
R42 |
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) |
RFA-CA-21-008 |
Related |
NCI
| 11-24-2020 |
01-22-2021 |
09-30-2021 |
U01 |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional) |
RFA-CA-21-009 |
Related |
NCI
| 11-24-2020 |
01-22-2021 |
09-30-2021 |
U54 |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) |
RFA-CA-21-010 |
Related |
NCI
| 11-24-2020 |
01-22-2021 |
09-30-2021 |
U2C |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) |
RFA-CA-21-011 |
Related |
NCI
| 11-24-2020 |
01-22-2021 |
09-30-2021 |
P01 |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) |
RFA-CA-21-012 |
Related |
NCI
| 11-24-2020 |
01-22-2021 |
09-30-2021 |
P50 |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) |
RFA-CA-21-007 |
Related |
NCI
| 11-24-2020 |
01-22-2021 |
09-30-2021 |
R01 |
Small Vessel VCID Biomarker Validation Consortium Sites (U01)(Clinical Trials Not Allowed) |
RFA-NS-21-005 |
Related |
NINDS
| 11-23-2020 |
02-09-2021 |
03-10-2021 |
U01 |
Small Vessel VCID Biomarkers Validation Consortium Coordinating Center (U24 Clinical Trial Not Allowed) |
RFA-NS-21-004 |
Related |
NINDS
| 11-23-2020 |
02-09-2021 |
03-10-2021 |
U24 |
Reconfiguration of GenitoUrinary Development Molecular Anatomy Project (GUDMAP) /(Re)Building A Kidney (RBK) Data Hub (U24 Clinical Trial Not Allowed) |
RFA-DK-20-014 |
Related |
NIDDK
| 11-23-2020 |
01-18-2021 |
02-19-2021 |
U24 |
GenitoUrinary Development Molecular Anatomy Project (GUDMAP) - Atlas Projects (U01 Clinical Trial Not Allowed) |
RFA-DK-20-013 |
Related |
NIDDK
| 11-23-2020 |
01-18-2021 |
02-19-2021 |
U01 |
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
RFA-CA-21-006 |
Related |
NCI
| 11-20-2020 |
01-22-2021 |
09-30-2021 |
R33 |
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) |
RFA-CA-21-005 |
Related |
NCI
| 11-20-2020 |
01-22-2021 |
09-30-2021 |
R21 |
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
RFA-CA-21-004 |
Related |
NCI
| 11-20-2020 |
01-22-2021 |
09-29-2021 |
R33 |
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) |
RFA-CA-21-003 |
Related |
NCI
| 11-20-2020 |
01-22-2021 |
09-30-2021 |
R21 |
Outstanding New Environmental Scientist (ONES) Award (R01 Clinical Trial Optional) |
RFA-ES-21-001 |
Related |
NIEHS
| 11-19-2020 |
01-26-2021 |
02-25-2023 |
R01 |
Diabetes Research Centers (P30 Clinical Trial Optional) |
RFA-DK-20-025 |
Related |
NIDDK
| 11-19-2020 |
04-20-2021 |
05-21-2021 |
P30 |
Contraceptive Development Research Centers Program (P50 Clinical Trial Optional) |
RFA-HD-22-003 |
Related |
NICHD
| 11-19-2020 |
02-28-2021 |
11-30-2021 |
P50 |
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional) |
RFA-MH-21-106 |
Related |
NIMH
| 11-18-2020 |
01-09-2021 |
02-10-2021 |
R21 |
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) |
RFA-MH-21-105 |
Related |
NIMH
| 11-18-2020 |
01-09-2021 |
02-10-2021 |
R01 |
Social Drivers of Mental Illnesses in Low- and Middle-Income Countries: Mechanisms and Pathways of Interventions for Youth (R01 Clinical Trial Optional) |
RFA-MH-21-160 |
Related |
NIMH
| 11-18-2020 |
02-18-2021 |
03-19-2021 |
R01 |
Exploratory Centers for Interdisciplinary Research in Benign Urology (P20 Clinical Trial Optional) |
RFA-DK-20-033 |
Related |
NIDDK
| 11-16-2020 |
02-18-2021 |
03-19-2021 |
P20 |
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R43/R44 Clinical Trial Optional) |
RFA-MH-21-112 |
Related |
NIMH
| 11-13-2020 |
01-18-2021 |
06-16-2022 |
R43/R44 |
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R34 Clinical Trial Optional) |
RFA-MH-21-111 |
Related |
NIMH
| 11-13-2020 |
01-18-2021 |
06-16-2022 |
R34 |
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R01 Clinical Trial Optional) |
RFA-MH-21-110 |
Related |
NIMH
| 11-13-2020 |
01-18-2021 |
06-16-2022 |
R01 |